That uptick, in part, was supported by Israeli-based generic drug giant Teva Pharmaceuticals Industries’ recent unsolicited $40 billion offer to buy smaller rival Mylan.
Thomson Reuters data shows that deals worth $194 billion have been announced in healthcare this year.
More articles on hospital transactions and valuation issues:
UC San Diego, Scripps Health collaborate in hospice care, training and research
3 reasons hospitals are avoiding mergers and choosing to affiliate instead
